Is the Current Regulation of Autologous Stem Cells Appropriate?

Posted 29 March 2017 By Dr. Ian Prosser

This article discusses the regulation of autologous stem cells and tissue therapies in Australia by addressing issues such as the safety and efficacy of cell therapies, which therapies are regulated, what regulators are doing in other countries and "next steps" in cell and tissue regulation.

Share this article:

Categories: Human cell and tissue, Features, US, Europe, Japan, Oceania, FDA, EMA, MHLW, PMDA, TGA

Tags: Autologous Stem Cells

Regulatory Exchange: Latest Updates From the Community